Gates Foundation Invests $40 Million in Immunotherapy Collaboration – BioPharm International
The Times |
Gates Foundation Invests $40 Million in Immunotherapy Collaboration
BioPharm International Gates Foundation Invests $40 Million in Immunotherapy Collaboration. The collaboration with Immunocore, a T cell receptor company, aims to discover and develop immunotherapy molecules to treat infectious diseases. Sep 19, 2017. By BioPharm … Gates Foundation invests $40 mln in UK immunotherapy companyReuters Gates foundation invests in British immunotherapy specialist …The Times Goalkeepers – The Stories Behind the Data – The Global GoalsThe Global Goals |
www.insideottawavalley.com/ |
Blood, stem cell drives pay tribute to Ashton resident’s courageous battle with cancer
www.insideottawavalley.com/ Becky Littau, seated, with her mother-in-law Judy just after donating blood during the Canadian Blood Services blood and stem cell drive Sept. 14 at the Almonte Civitan Club. This clinic and another Oct. 2 in Kemptville are being held in honour of … |
Scientific American |
Can Scientists Convince the Public to Accept CRISPR and Gene Drives?
Scientific American In 1999 Robert Shapiro, then head of Monsanto, gave a stunning mea culpa at a Greenpeace conference in London. Monsanto’s first genetically engineered (GE) crops had been on the market for only three years, but they were facing fierce public backlash. |
Scientific American |
Can Scientists Convince the Public to Accept CRISPR and Gene Drives?
Scientific American In 1999 Robert Shapiro, then head of Monsanto, gave a stunning mea culpa at a Greenpeace conference in London. Monsanto’s first genetically engineered (GE) crops had been on the market for only three years, but they were facing fierce public backlash. |
|
Irvine Scientific Introduces Chemically-Defined Dendritic Cell Culture Medium for Immunotherapy Applications
Business Wire (press release) SANTA ANA, Calif.–(BUSINESS WIRE)–Irvine Scientific, a world leader in cell culture media development and manufacture, today announced the introduction of PRIME-XV® Dendritic Cell Maturation CDM, a chemically-defined, animal component-free … |
|
Imstem secures patent for stem cell therapies
Global University Venturing Imstem Biotechnology, a US-based stem cell technology spinout from University of Connecticut, has been awarded a joint patent with the institution for a stem cell-based treatment of autoimmune diseases. ImStem’s T-MSC cell therapy is primarily aimed at … |
|
Gene therapy could be novel approach to treat alcoholism, research suggests
News-Medical.net In the article titled “AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells” researchers Anamaria Sanchez, University of Chile, Santiago and R. Jude Samulski, University of North … |